Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011241 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Yi-Sheng Kao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Dengue, Dengue Virus, Interferon Type I. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, National Health Research Institutes, Taiwan.
Abstract (Originalsprache)
Dengue virus (DENV) infection can induce life-threatening dengue hemorrhagic fever/dengue shock syndrome in infected patients. DENV is a threat to global health due to its growing numbers and incidence of infection in the last 50 years. During infection, DENV expresses ten structural and nonstructural proteins modulating cell responses to benefit viral replication. However, the lack of knowledge regarding the cellular proteins and their functions in enhancing DENV pathogenesis impedes the development of antiviral drugs and therapies against fatal DENV infection. Here, we identified that integrin-linked kinase (ILK) is a novel enhancing factor for DENV infection by suppressing type I interferon (IFN) responses. Mechanistically, ILK binds DENV NS1 and NS3, activates Akt and Erk, and induces NF-κB-driven suppressor of cytokine signaling 3 (SOCS3) expression. Elevated SOCS3 in DENV-infected cells inhibits phosphorylation of STAT1/2 and expression of interferon-stimulated genes (ISGs). Inhibiting ILK, Akt, or Erk activation abrogates SOCS3 expression. In DENV-infected mice, the treatment of an ILK inhibitor significantly reduces viral loads in the brains, disease severity, and mortality rate. Collectively, our results show that ILK is a potential therapeutic target against DENV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- School of Medicine, I-Shou University, Kaohsiung, Taiwan.
- The Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan, Taiwan.
- Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.
ORCID-Profile: Chih-Peng Chang
Förderung
- Ministry of Science and Technology, Taiwan
- National Health Research Institutes, Taiwan
Zitieren
APA
Kao, Y. S., Wang, L. C., Chang, P. C., Lin, H. M., Lin, Y. S., Yu, C. Y., Chen, C. C., Lin, C. F., Yeh, T. M., Wan, S. W., Wang, J. R., Ho, T. S., Chu, C. C., Zhang, B. C., & Chang, C. P. (2023). Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011241
Vancouver
Kao YS, Wang LC, Chang PC, Lin HM, Lin YS, Yu CY, et al. Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011241
BibTeX
@article{Kao2023,
author = {Kao, Yi-Sheng and Wang, Li-Chiu and Chang, Po-Chun and Lin, Heng-Ming and Lin, Yee-Shin and Yu, Chia-Yi and Chen, Chien-Chin and Lin, Chiou-Feng and Yeh, Trai-Ming and Wan, Shu-Wen and Wang, Jen-Ren and Ho, Tzong-Shiann and Chu, Chien-Chou and Zhang, Bo-Cheng and Chang, Chih-Peng},
title = {Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011241}
}
EUVIMED